Manganese for Wound Healing and Connective Tissue Repair

Pineapple, a manganese-rich fruit
Pineapple, a manganese-rich fruit

Wound healing is a four-phase orchestration: hemostasis, inflammation, proliferation, and remodeling. Each phase requires intact connective tissue biochemistry, and manganese is a critical cofactor at multiple points in that biochemistry. Manganese activates prolidase, the dipeptidase that recycles proline from degraded collagen for use in new collagen synthesis — the rare inherited disorder prolidase deficiency produces severe non-healing skin ulcers and demonstrates how essential this single enzyme is for tissue repair. Manganese also activates the family of glycosyltransferases that assemble the proteoglycan ground substance (chondroitin sulfate, hyaluronan) which provides the hydrated scaffold for fibroblast and keratinocyte migration into a wound bed. And manganese superoxide dismutase (MnSOD) protects metabolically active fibroblasts and chondrocytes from the oxidative bursts that accompany inflammation. The result: wounds in manganese-deficient hosts heal more slowly, with weaker scar tensile strength and disorganized matrix.


Table of Contents

  1. Why Wound Healing Depends on Manganese
  2. The Four Phases of Wound Healing
  3. Prolidase: The Collagen-Recycling Enzyme
  4. Prolidase Deficiency Syndrome: The Natural Experiment
  5. Glycosyltransferases and the Provisional Wound Matrix
  6. Chondrocyte Function and Cartilage Repair
  7. MnSOD and the Inflammatory Phase
  8. Angiogenesis and Granulation Tissue
  9. Clinical Applications: Diabetic Wounds, Surgical Recovery, Burn Care
  10. Doses Studied and Safety Facts
  11. Key Research Papers
  12. Connections
  13. Featured Videos

Why Wound Healing Depends on Manganese

Connective tissue is structurally dominated by collagen (about 75% of dry weight of dermis) embedded in a ground substance of proteoglycans and glycosaminoglycans. When tissue is injured, both components must be replaced rapidly. The body's machinery for accomplishing this has three manganese-critical components:

  1. Collagen substrate recycling — one-third of every collagen molecule is proline or hydroxyproline. The body has a limited capacity to synthesize proline de novo, so collagen turnover relies heavily on recycling proline from degraded collagen via prolidase. Prolidase is a manganese-activated enzyme.
  2. Ground substance assembly — the proteoglycans (chondroitin sulfate, heparan sulfate, hyaluronan-binding aggrecan) that fill the matrix between collagen fibrils are built by manganese-dependent glycosyltransferases.
  3. Cellular antioxidant defense — fibroblasts, chondrocytes, and endothelial cells engaged in active matrix synthesis have high mitochondrial activity. MnSOD in their mitochondria is the primary defense against the oxidative byproducts of that synthesis.

These three roles are layered. A manganese-deficient wound has slow collagen turnover (poor prolidase activity), weak ground substance (poor glycosyltransferase activity), and damaged matrix-producing cells (poor MnSOD activity). Each defect alone would slow healing; in combination, they produce a measurable clinical impairment.

Back to Table of Contents

The Four Phases of Wound Healing

Modern wound biology recognizes four temporally overlapping phases. Manganese contributes to each, but most prominently to phases 3 and 4.

Back to Table of Contents

Prolidase: The Collagen-Recycling Enzyme

Prolidase (also called peptidase D, PEPD, or imidodipeptidase) is a cytosolic metallopeptidase that hydrolyzes dipeptides containing C-terminal proline or hydroxyproline. It is the final step of collagen catabolism: collagen is degraded by collagenases (matrix metalloproteinases, MMPs) to small peptides, those peptides are further hydrolyzed by general peptidases to amino acid pairs ending in proline (since proline is so frequent in collagen), and prolidase cleaves the last bond to release free proline.

Back to Table of Contents

Prolidase Deficiency Syndrome: The Natural Experiment

The clinical importance of prolidase is most clearly seen in the rare autosomal recessive disorder of prolidase deficiency (Online Mendelian Inheritance in Man, OMIM 170100), caused by loss-of-function mutations in the PEPD (peptidase D) gene. Patients have essentially absent prolidase activity and accumulate iminodipeptides in plasma and urine (massive imidodipeptiduria is the diagnostic finding).

The clinical phenotype is striking and centers on skin and connective tissue:

The disorder is broader than the skin. A 2021 review that described 19 new patients and 161 published cases found that half of the published patients had symptoms by age 4 and that diagnosis came on average 11.6 years late. Autoimmune diseases such as lupus, Crohn disease or arthritis were found in 6 of the 19 newly described patients, and some patients developed a dangerous immune over-reaction (hemophagocytic lymphohistiocytosis).

The disorder is essentially untreatable in any curative sense, but case reports have described improvement in ulcer healing with topical proline supplementation, oral proline + vitamin C + manganese (to maximize residual prolidase function), and aggressive wound bed preparation. The natural experiment confirms: without functioning prolidase, wound healing fundamentally fails.

It is a hypothesis, drawn from the enzyme’s need for manganese, that the much more common situation of marginal manganese status lowers prolidase activity enough to slow wound healing without producing the full prolidase deficiency picture; none of the prolidase studies cited on this page measured this in people. In a 1976 gelatin-loading study, adult carriers of the disorder (heterozygotes) excreted only slightly more bound hydroxyproline than adult controls. If the hypothesis held, it would matter most for diabetic foot ulcers, pressure ulcers and slow healing after surgery in older people.

Back to Table of Contents

Glycosyltransferases and the Provisional Wound Matrix

Within hours of injury, the wound bed fills with a provisional matrix dominated by fibrin (from the initial clot) and hyaluronan (synthesized by fibroblasts and endothelial cells migrating in). Over the following days, this provisional matrix is progressively replaced by a more permanent matrix of collagen, decorin, biglycan, and chondroitin-sulfate proteoglycans.

Manganese-dependent glycosyltransferases assemble the glycosaminoglycan (GAG) side chains on these proteoglycans:

Adequate ground substance is essential for fibroblast and keratinocyte migration. Cells migrate along proteoglycan and fibronectin tracks; an under-built matrix produces slower cellular migration and delayed re-epithelialization.

Back to Table of Contents

Chondrocyte Function and Cartilage Repair

Cartilage repair is qualitatively different from skin repair because of cartilage's avascularity. Articular cartilage has no blood supply, limited cellular density, and a very slow matrix turnover rate. When cartilage is damaged, the resident chondrocyte population must do all of the repair work itself, and chondrocyte function depends critically on manganese.

For the broader manganese-cartilage story, see also the manganese and bone formation deep-dive on endochondral ossification.

Back to Table of Contents

MnSOD and the Inflammatory Phase

The inflammatory phase of wound healing is necessary but double-edged. Activated neutrophils and macrophages produce massive amounts of superoxide via the reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase respiratory burst as their primary antibacterial weapon. This superoxide is essential for killing invading bacteria, but it also damages surrounding host tissue if not contained.

MnSOD in the mitochondria of neighboring fibroblasts, endothelial cells, and uninjured keratinocytes provides containment. When MnSOD is adequate, the oxidative damage is localized to the immediate inflammatory zone, and the surrounding tissue remains healthy and ready to enter the proliferation phase. When MnSOD is inadequate, oxidative damage spreads, healthy tissue is collateral damage, and the inflammation phase prolongs into a chronic non-healing state.

This is the mechanistic explanation for one of the most stubborn problems in wound care: chronic non-healing wounds (diabetic foot ulcers, venous stasis ulcers, pressure ulcers) often appear "stuck" in the inflammatory phase, with persistent infiltration of neutrophils, ongoing oxidative damage, and failure to transition to proliferation. Multiple inputs can contribute (poor perfusion, infection, repeated mechanical injury), but inadequate cellular antioxidant defense is consistently part of the picture.

The therapeutic implication is supporting the host's antioxidant defenses (MnSOD via manganese, glutathione via cysteine and glycine, vitamin E, vitamin C, selenium) as part of comprehensive chronic-wound care. For deeper coverage of the MnSOD mechanism, see the antioxidant MnSOD deep-dive.

Back to Table of Contents

Angiogenesis and Granulation Tissue

The proliferation phase of wound healing is characterized by the formation of granulation tissue — a pink, beefy, friable matrix consisting of newly forming capillaries, fibroblasts, and provisional extracellular matrix. The capillary network of granulation tissue forms through angiogenesis, in which endothelial cells from existing wound-edge vessels sprout into the wound bed.

Manganese supports angiogenesis through several routes:

Back to Table of Contents

Clinical Applications: Diabetic Wounds, Surgical Recovery, Burn Care

The 2022 European Society for Clinical Nutrition and Metabolism (ESPEN) micronutrient guideline covers 26 vitamins and trace elements with 170 recommendations, but it notes that the number of intervention trials is limited and the level of evidence low.

Back to Table of Contents

Doses Studied and Safety Facts

This content is provided for informational purposes only and does not constitute medical advice. Chronic non-healing wounds are treated in wound clinics with several measures at once; nutrition is one of them.

Back to Table of Contents

Key Research Papers

  1. Lupi A, Della Torre S, Campari E, Tenni R, Cetta G, Rossi A, Forlino A (2006). Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. FEBS Journal 273(23):5466-5478. — PubMed PMID: 17081196
  2. Phang JM, Liu W (2012). Proline metabolism and cancer. Frontiers in Bioscience (Landmark Edition) 17(5):1835-1845. — PubMed PMID: 22201839
  3. Kitchener RL, Grunden AM (2012). Prolidase function in proline metabolism and its medical and biotechnological applications. Journal of Applied Microbiology 113(2):233-247. — PubMed PMID: 22512465
  4. Lupi A, Tenni R, Rossi A, Cetta G, Forlino A (2008). Human prolidase and prolidase deficiency. Amino Acids 35(4):739-752. — PubMed PMID: 18340504
  5. Powell GF, Maniscalco RM (1976). Bound hydroxyproline excretion following gelatin loading in prolidase deficiency. Metabolism 25(5):503-508. — PubMed PMID: 772363
  6. Heyland DK et al. (2005). Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Medicine 31(3):327-337. — PubMed PMID: 15605227
  7. Berger MM, Shenkin A (2007). Trace element requirements in critically ill burned patients. Journal of Trace Elements in Medicine and Biology 21 Suppl 1:44-48. — PubMed PMID: 18039496
  8. Stechmiller JK (2010). Understanding the role of nutrition and wound healing. Nutrition in Clinical Practice 25(1):61-68. — PubMed PMID: 20130158
  9. Posthauer ME et al. (2015). The role of nutrition for pressure ulcer management: National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel, and Pan Pacific Pressure Injury Alliance white paper. Advances in Skin & Wound Care 28(4):175-188. — PubMed PMID: 25775201
  10. Reiber GE, Vileikyte L, Boyko EJ et al. (1999). Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22(1):157-162. — PubMed PMID: 10333919
  11. Hurley LS, Keen CL (1987). Manganese. In: Trace Elements in Human and Animal Nutrition. — Search PubMed
  12. Leach RM, Muenster AM, Wien EM (1969). Studies on the role of manganese in bone formation. II. Effect upon chondroitin sulfate synthesis in chick epiphyseal cartilage. Archives of Biochemistry and Biophysics 133(1):22-28. — PubMed PMID: 5810830
  13. Rossignol F, Duarte Moreno MS, Benoist JF, et al. (2021). Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases. Genetics in Medicine 23(9):1604-1615. — PubMed PMID: 34040193
  14. Berger MM, Eggimann P, Heyland DK, Chioléro RL, Revelly JP, Day A, Raffoul W, Shenkin A (2006). Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Critical Care 10(6):R153. — PubMed PMID: 17081282
  15. Cereda E, Neyens JCL, Caccialanza R, Rondanelli M, Schols JMGA (2017). Efficacy of a Disease-Specific Nutritional Support for Pressure Ulcer Healing: A Systematic Review and Meta-Analysis. Journal of Nutrition, Health & Aging 21(6):655-661. — PubMed PMID: 28537329
  16. Carollo M, Ingrasciotta Y, Crisafulli S, et al. (2026). Global Epidemiology of Diabetic Foot: A Systematic Review and Meta-Analysis. Diabetes/Metabolism Research and Reviews 42(6):e70223. — PubMed PMID: 42671083
  17. Berger MM, Shenkin A, Schweinlin A, et al. (2022). ESPEN micronutrient guideline. Clinical Nutrition 41(6):1357-1424. — PubMed PMID: 35365361

PubMed Topic Searches

  1. PubMed: Prolidase + wound healing
  2. PubMed: Manganese + glycosyltransferase
  3. PubMed: Trace minerals + chronic wound
  4. PubMed: Diabetic foot ulcer + nutrition
  5. PubMed: Burn + trace mineral supplementation

Back to Table of Contents

Connections

Back to Table of Contents